Search the Newsreel

Eli Lilly (LLY) Adds Neuroscience And Lung Cancer Research Deals

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Eli Lilly (NYSE: LLY) announced new global collaborations focused on ion channel drug discovery with OmniAb and a trial partnership with Amplia Therapeutics …

Eli Lilly and Company (NYSE:LLY) Stock Price Up 3.7% - What's Next?

Eli Lilly and Company (NYSE:LLY) shares increased by 3.7% to approximately $1,227, driven by optimism regarding its oral obesity drug prospects and positive developments for its next-generation candidate, retatrutide. The company is also expanding its pipeline through collaborations, including an ion-channel program with OmniAb …

Fidelity National Information Services (FIS) Could Be 20% Undervalued Following Strong Earnings

Fidelity National Information Services (FIS) is considered 19.8% undervalued with a fair value of $51.04, despite a recent share price decline. The company reported strong Q2 earnings and expanded its Digital One Commercial banking platform into APAC, alongside introducing new AI-powered fintech solutions. Analysts …

Bridgeline Digital posts $3.9M revenue in Q3 FY2026, narrows quarterly net loss to $0.5M

Bridgeline Digital reported total revenue of $3.9 million for Q3 FY2026, with subscription revenue at $3.1 million. The company narrowed its net loss to $0.5 million for the quarter, an improvement from $0.8 million a year prior. Key business highlights included a record-tying number …

Eli Lilly and Co(LLY.US) Officer Sells US$7.64 Million in Common Stock

An officer at Eli Lilly and Co (LLY.US) sold 9,936 shares of common stock for a total of $7.64 million on August 16, 2026, at an average price of $769.19 per share. This transaction was disclosed in a Form 4 filing with the SEC. …

Elicio (ELTX) Financial Update: Reported EPS Misses Expectations for This Review; Reaction Snapshot: Shares Move Higher 2.98% in Latest Trading - Share Dilution Risk

Helios (HLIO) Quarterly Figures: The EPS Result Is Above Expectation in the Latest Reading; Share-Price Check

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send?

Eli Lilly and Co (LLY) stock rose 3.19% on August 18, driven by strong second-quarter earnings, an upgraded full-year outlook, and high demand for its Mounjaro and Zepbound treatments. Analysts have issued "Buy" ratings with an average price target of $1296.81, reflecting investor confidence …

Eli Lilly Stock Jumps 2.6% as Investors Flee Expensive Tech

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY), the pharmaceutical powerhouse behind Mounjaro and Zepbound, jumped approximately 2.6% to $1,213.76 Tuesday morning as investors searched for earnings growth outside pressured technology stocks. With its market capitalization climbing above $1.08 trillion, Lilly is proving …

Why Helix BioPharma Corp. stock is gaining today

ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints

Eli Lilly, Stock Of The Day, Is Erasing Novo's Early Lead In Weight-Loss Pills

Eli Lilly is Tuesday's IBD Stock Of The Day. Shares are staring down two potential entries as the weight-loss kingpin gains on Novo Nordisk. Continue Reading

Beeline Holdings (NASDAQ: BLNE) Reports 57% Revenue Growth, Improved Margins in Q2 2026

Tata Consultancy Services Stock Leads 3 Dividend Powerhouses For Reliable Income

Eli Lilly's Zepbound Sales Jump 46%, Dominating Obesity Market

Eli Lilly's Zepbound has seen a significant 46% increase in sales, positioning it as a dominant player in the obesity market. This growth highlights the drug's strong performance and its increasing impact within the pharmaceutical industry.

Why Did Helix BioPharma (TSX:HBP) Stock Surge 8.02% on 17 August 2026?

BLIN Looks 7.4% Undervalued on GF Value™

Bridgeline Digital Inc (NASDAQ: BLIN) has successfully deployed its HawkSearch AI platform for a major automotive eCommerce network, handling 2.4 million product entries. While its Price-to-Sales ratio is slightly above its historical median, the company is unprofitable, making traditional earnings-based valuations inapplicable. GuruFocus's GF …

Elicio Therapeutics' (ELTX) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright has reaffirmed its "Buy" rating for Elicio Therapeutics (ELTX), with an average analyst price target of $19.75, indicating a "Moderate Buy" consensus. Despite this, ELTX shares opened down 2.3% at $3.02, trading below key moving averages and near its 52-week low. The …

ETFs Investing in Polibeli Group Ltd Class A Stocks

This article lists ETFs that invest in Polibeli Group Ltd Class A stocks, sorted by market value. It highlights the Fidelity Nasdaq Composite Index ETF (ONEQ) as one such fund, providing details like market value, weight, issuer, and performance. The purpose is to make …

Bridgeline's AI search cuts hierarchy-filter response times 91% on 2.4M products

Bridgeline Digital (NASDAQ: BLIN) announced the successful deployment of its HawkSearch AI platform for a major North American automotive eCommerce network, managing 2.4 million product records. This implementation significantly reduced product indexing time from 20 to 3 hours and improved hierarchy facet response times …

Why Is Omniab Stock Rallying After Eli Lilly Deal?

OmniAb, Inc. (NASDAQ: OABI) shares surged after the company announced a global collaboration and license agreement with Eli Lilly and Company (NYSE: LLY) for an ion channel program. The deal includes an upfront payment and up to $370 million in potential milestone payments, along …

Elicio Therapeutics stock price target reiterated at $23 by H.C. Wainwright

H.C. Wainwright has reiterated a Buy rating and a $23 price target for Elicio Therapeutics (NASDAQ:ELTX) after the company reported its second-quarter 2026 results. Despite a significant stock price drop, analyst consensus remains at Strong Buy, and the company has secured $15 million in …

BLIN Q2 2026 Earnings: EPS Misses Consensus as Losses Persist - Post-Earnings Drift

Onelife Capital Advisors Q1 Results: Files Q1FY26 financials with exchanges

Pallas Capital Advisors LLC Invests $1.67 Million in Exelixis, Inc. $EXEL

Pallas Capital Advisors LLC has invested $1.67 million in Exelixis, Inc. by purchasing 30,721 shares in the second quarter. Institutional investors and hedge funds collectively own a significant 85.27% of the biotechnology company's stock. Exelixis recently reported strong quarterly earnings, beating EPS estimates, and …

Reliance Worldwide Shares Lead ASX 200: Takeover Bid Overshadows Falling Profit

Helix BioPharma Stock Gains Bullish Momentum as Clinical Strategy and Leadership Catalyst Lift Investor Optimism

Barclays Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

Barclays analyst Emily Field has reiterated a Buy rating on Eli Lilly & Co (LLY) with a price target of $1,400.00. This comes after Eli Lilly reported strong quarterly revenues of $22.97 billion and a net profit of $7.1 billion, significantly up from the …

Form 8K HELIX ACQUISITION CORP. III For: 17 August By Investing.com

This article reports on the filing of Form 8K by HELIX ACQUISITION CORP. III for August 17. The filing is presented without additional commentary or details, serving as a notice of the company's regulatory submission. It includes financial market data and other Investing.com content …

135,551 Shares in Pembina Pipeline Corp. $PBA Acquired by K.J. Harrison & Partners Inc

K.J. Harrison & Partners Inc. acquired 135,551 shares of Pembina Pipeline Corp. (NYSE:PBA) valued at approximately $6.26 million during the second quarter, making it their 28th biggest holding. Other institutional investors also adjusted their positions in the company, with total institutional ownership standing at …

Diamond Hill Capital Management LLC Investment Advisor Purchases Shares of 14,061 Helios Technologies, Inc $HLIO

Diamond Hill Capital Management LLC has acquired 14,061 shares of Helios Technologies, Inc (HLIO), valued at approximately $1.26 million, marking a new position for the investment advisor. Helios Technologies recently reported strong quarterly earnings, beating estimates with $0.88 EPS and a 9.1% revenue increase …

27,109 Shares in Exelixis, Inc. $EXEL Purchased by Grandfield & Dodd LLC

Grandfield & Dodd LLC has acquired 27,109 shares of Exelixis, Inc. (NASDAQ:EXEL) during the second quarter, valued at approximately $1.48 million. This purchase contributes to the 85.27% of the stock already owned by institutional investors. Despite the company beating earnings estimates with $0.91 per …

Javelin Minerals Issues 15 Million Unquoted Options Under JAVAA

Helix Acquisition Corp. III Gets Nasdaq Deficiency Notice for Falling Below 300 Total Holders

Helix Acquisition Corp. III (NASDAQ: HLXC) received a Nasdaq deficiency notice because it failed to maintain the required minimum of 300 Total Holders for continued listing on the Nasdaq Global Market. The company has 45 days to submit a compliance plan, and failure to …

Elixir Energy (ASX:EXR): What Could Gas Flow Results Mean for This Penny Stock?

Brookfield lobs $4.1b bid for plumbing giant Reliance Worldwide